211-225 of 931

Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®Oncogenic Drivers in Never-Smokers with NSCLC

Expanding Molecular Testing in Community NSCLC Care
Project Oncology®Expanding Molecular Testing in Community NSCLC Care

Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care

Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast CancerAddressing Unmet Needs in First-Line mTNBC Care

Optimizing Care for Older Adults With FLT3-Mutated AML
On the Frontlines of AML/ALLOptimizing Care for Older Adults With FLT3-Mutated AML

Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerBiomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
- advertisement

Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®Modern Management of ROS1-Positive Non-Small Cell Lung Cancer

Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstractsUnderstanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer

Bridging Gaps with Blood-Based CRC Screening
On the Frontlines of Colorectal CancerBridging Gaps with Blood-Based CRC Screening

Evolving Strategies in CRC Care: Screening, Treatment, and Equity
On the Frontlines of Colorectal CancerEvolving Strategies in CRC Care: Screening, Treatment, and Equity

Prioritizing Quality of Life in CRC: Key Surgical Considerations
On the Frontlines of Colorectal CancerPrioritizing Quality of Life in CRC: Key Surgical Considerations

How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
- advertisement

How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse

Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade

What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology








































